X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (36485) 36485
Journal Article (9944) 9944
Publication (1051) 1051
Book Review (249) 249
Newsletter (130) 130
Book Chapter (129) 129
Book / eBook (63) 63
Conference Proceeding (22) 22
Magazine Article (17) 17
Dissertation (13) 13
Newspaper Article (6) 6
Web Resource (5) 5
Data Set (3) 3
Streaming Video (2) 2
Transcript (2) 2
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
nucleosides (38942) 38942
nucleotides (37029) 37029
chemistry (36807) 36807
nucleic acids (36674) 36674
organic chemistry (36669) 36669
sugars (36549) 36549
derivatives thereof (36485) 36485
metallurgy (36485) 36485
human necessities (35464) 35464
hygiene (35366) 35366
medical or veterinary science (35366) 35366
preparations for medical, dental, or toilet purposes (34831) 34831
specific therapeutic activity of chemical compounds ormedicinal preparations (32031) 32031
microbiology (17092) 17092
biochemistry (16791) 16791
enzymology (16555) 16555
beer (16534) 16534
wine (16534) 16534
mutation or genetic engineering (16533) 16533
spirits (16533) 16533
vinegar (16533) 16533
culture media (14147) 14147
compositions thereof (14132) 14132
microorganisms or enzymes (14132) 14132
propagating, preserving or maintaining microorganisms (14132) 14132
peptides (10897) 10897
heterocyclic compounds (8055) 8055
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (7831) 7831
humans (6183) 6183
general tagging of cross-sectional technologies spanning over several sections of the ipc (5942) 5942
general tagging of new technological developments (5942) 5942
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (5942) 5942
physics (5766) 5766
testing (5583) 5583
measuring (5570) 5570
investigating or analysing materials by determining theirchemical or physical properties (5558) 5558
compositions or test papers therefor (5518) 5518
condition-responsive control in microbiological orenzymological processes (5518) 5518
measuring or testing processes involving enzymes, nucleicacids or microorganisms (5518) 5518
processes of preparing such compositions (5518) 5518
index medicus (4020) 4020
specific use of cosmetics or similar toiletpreparations (3903) 3903
technologies or applications for mitigation or adaptation againstclimate change (3178) 3178
technical subjects covered by former uspc (3039) 3039
trapping (3032) 3032
agriculture (3031) 3031
animal husbandry (3029) 3029
fishing (3029) 3029
forestry (3029) 3029
hunting (3029) 3029
processes using microorganisms (2876) 2876
animals (2824) 2824
technical subjects covered by former uspc cross-reference artcollections [xracs] and digests (2822) 2822
acyclic, carbocyclic or heterocyclic compounds containingelements other than carbon, hydrogen, halogen, oxygen, nitrogen,sulfur, selenium or tellurium (2458) 2458
technologies for adaptation to climate change (2344) 2344
acyclic or carbocyclic compounds (2249) 2249
pharmacology & pharmacy (2196) 2196
male (2119) 2119
female (2091) 2091
foods or foodstuffs (2039) 2039
their treatment, not covered by other classes (2039) 2039
compositions based thereon (1692) 1692
organic macromolecular compounds (1692) 1692
their preparation or chemical working-up (1692) 1692
foods, foodstuffs, or non-alcoholic beverages, not covered bysubclasses a23b - a23j (1665) 1665
preservation of foods or foodstuffs, in general (1665) 1665
their preparation or treatment, e.g. cooking, modification ofnutritive qualities, physical treatment (1665) 1665
biocides, e.g. as disinfectants, as pesticides, as herbicides (1553) 1553
pest repellants or attractants (1553) 1553
plant growth regulators (1553) 1553
preservation of bodies of humans or animals or plants or partsthereof (1553) 1553
enzymes (1506) 1506
adult (1376) 1376
care of birds, fishes, insects (1354) 1354
new breeds of animals (1354) 1354
rearing or breeding animals, not otherwise provided for (1354) 1354
polysaccharides (1340) 1340
performing operations (1263) 1263
transporting (1263) 1263
nucleoside analogs (1252) 1252
middle aged (1185) 1185
hiv infections - drug therapy (1169) 1169
mice (1141) 1141
antiviral agents - therapeutic use (1135) 1135
biochemistry & molecular biology (1134) 1134
nucleosides - therapeutic use (1023) 1023
antiviral agents (992) 992
nanotechnology (985) 985
manufacture or treatment of nanostructures (959) 959
measurement or analysis of nanostructures (959) 959
specific uses or applications of nanostructures (959) 959
infectious diseases (938) 938
hiv (931) 931
oncology (928) 928
cancer (913) 913
climate change mitigation technologies in the production orprocessing of goods (869) 869
chemistry, medicinal (827) 827
analysis (813) 813
treatment outcome (778) 778
virology (775) 775
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (43) 43
Collection Dvlpm't (Acquisitions) - Closed Orders (10) 10
Chemistry (A D Allen) - Stacks (8) 8
UofT at Mississauga - Stacks (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Online Resources - Online (6) 6
UofT at Scarborough - Stacks (4) 4
UTL at Downsview - May be requested (3) 3
Robarts - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Gerstein Science - Circulation Desk (1) 1
Law (Bora Laskin) - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (43213) 43213
French (11451) 11451
German (5391) 5391
Chinese (2038) 2038
Spanish (811) 811
Japanese (745) 745
Korean (532) 532
Norwegian (466) 466
Russian (415) 415
Portuguese (412) 412
Czech (247) 247
Hungarian (198) 198
Danish (191) 191
Polish (141) 141
Finnish (131) 131
Slovak (114) 114
Slovenian (99) 99
Hebrew (82) 82
Italian (82) 82
Swedish (82) 82
Bulgarian (70) 70
Turkish (60) 60
Serbian (59) 59
Estonian (54) 54
Croatian (52) 52
Icelandic (52) 52
Dutch (48) 48
Ukrainian (41) 41
Greek (27) 27
Lithuanian (21) 21
Romanian (11) 11
Arabic (9) 9
Bosnian (6) 6
Indonesian (2) 2
Latvian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2011, Methods in molecular biology, ISBN 9781617791871, Volume 764., xi, 340
Book
Mayo Clinic Proceedings, ISSN 0025-6196, 2011, Volume 86, Issue 10, pp. 1009 - 1026
Abstract Most viral diseases, with the exception of those caused by human immunodeficiency virus, are self-limited illnesses that do not require specific... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | HERPES-SIMPLEX-VIRUS | TENOFOVIR DISOPROXIL FUMARATE | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | POSITIVE CHRONIC HEPATITIS | CHRONIC HEPATITIS-B | ALPHA-2A PLUS RIBAVIRIN | CONGO HEMORRHAGIC-FEVER | ACUTE INTERSTITIAL NEPHRITIS | RECURRENT GENITAL HERPES | HIV-INFECTED PATIENTS | Acyclovir - therapeutic use | Foscarnet - pharmacology | Hepatitis C - drug therapy | HIV Infections - epidemiology | Humans | Ganciclovir - analogs & derivatives | Interferons - therapeutic use | Oligopeptides - therapeutic use | Hepatitis - drug therapy | Adenine - therapeutic use | Lamivudine - therapeutic use | Ganciclovir - therapeutic use | Proline - pharmacology | Protease Inhibitors - therapeutic use | Guanine - therapeutic use | Oseltamivir - pharmacology | Virus Replication - drug effects | Antiviral Agents - pharmacology | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Proline - analogs & derivatives | Antiviral Agents - therapeutic use | Comorbidity | Interferons - pharmacology | Pyrimidinones - therapeutic use | Acyclovir - pharmacology | Zanamivir - therapeutic use | Herpesviridae Infections - drug therapy | Thymidine - analogs & derivatives | Valine - therapeutic use | Oligopeptides - pharmacology | Ribavirin - pharmacology | Guanine - analogs & derivatives | Oseltamivir - therapeutic use | Guanine - pharmacology | Hepatitis C - epidemiology | Nucleosides - pharmacology | Ganciclovir - pharmacology | Pyrimidinones - pharmacology | Influenza, Human - drug therapy | Drug Therapy, Combination | Nucleosides - therapeutic use | Acyclovir - analogs & derivatives | Ribavirin - therapeutic use | Valine - analogs & derivatives | Zanamivir - pharmacology | Adenine - pharmacology | Proline - therapeutic use | Organophosphonates - pharmacology | Hepatitis B, Chronic - drug therapy | HIV Infections - drug therapy | Lamivudine - pharmacology | Foscarnet - therapeutic use | Valine - pharmacology | Amantadine - pharmacology | Antiviral agents | Diagnosis | Research | Drug therapy | HIV infection | Health aspects | Symposium on Antimicrobial Therapy
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2014, Volume 40, Issue 9, pp. 1080 - 1088
Highlights • PTCL has a poor prognosis; existing therapies are insufficient. • We summarize current evidence on novel therapies for relapsed/refractory PTCL. •... 
Hematology, Oncology and Palliative Medicine | Antifolate | Nucleoside analog | Histone deacetylase inhibitor | Fusion protein | Peripheral T-cell lymphoma | Immunomodulatory agent | DENILEUKIN DIFTITOX | NON-HODGKINS-LYMPHOMAS | FOLLOW-UP | BRENTUXIMAB VEDOTIN SGN-35 | OPEN-LABEL | ALLOGENEIC TRANSPLANTATION | SINGLE-AGENT | PHASE-II TRIAL | ONCOLOGY | SALVAGE THERAPY | HIGH-DOSE CHEMOTHERAPY | Doxorubicin - therapeutic use | Humans | Recombinant Fusion Proteins - therapeutic use | Interleukin-2 - therapeutic use | Neoplasm Recurrence, Local - drug therapy | Antineoplastic Agents - therapeutic use | Cyclophosphamide - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Folic Acid Antagonists - therapeutic use | Stem Cell Transplantation | Topoisomerase Inhibitors - pharmacology | Thalidomide - analogs & derivatives | Diphtheria Toxin - therapeutic use | Topoisomerase Inhibitors - therapeutic use | Immunoconjugates - therapeutic use | Antineoplastic Agents - pharmacology | Depsipeptides - therapeutic use | Prednisolone - therapeutic use | Lymphoma, T-Cell, Peripheral - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Alemtuzumab | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, T-Cell, Peripheral - pathology | Vincristine - therapeutic use | Histone Deacetylase Inhibitors - therapeutic use | Lymphoma, T-Cell, Peripheral - therapy | Thalidomide - therapeutic use | Folic Acid Antagonists - pharmacology | Care and treatment | Lymphomas | T cells | Health aspects
Journal Article
Pharmaceutical patent analyst, 11/2018, Volume 7, Issue 6, pp. 277 - 299
Fluorinated nucleosides constitute a large class of chemotherapeutics approved for clinical use. The pharmacokinetic and pharmacodynamic properties of a drug... 
Fluorinated-nucleosides | phosph(on)ate prodrugs | F-PET tracers | antiviral | nucleophilic fluorination | N-glycosylation | anticancer
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 229 - 237
Summary Background The non-nucleoside reverse transcriptase inhibitor (NNRTI), rilpivirine (TMC278; Tibotec Pharmaceuticals, County Cork, Ireland), had... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | ZIDOVUDINE | COMBINATION THERAPY | ACTIVE ANTIRETROVIRAL THERAPY | EMTRICITABINE | PROTEASE-INHIBITOR | CYSTATIN-C | CREATININE | DAILY LAMIVUDINE | NEVIRAPINE | TENOFOVIR | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Nucleotides - therapeutic use | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Nucleosides - therapeutic use | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Benzoxazines - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Evaluation | Patient outcomes | Clinical trials | Dosage and administration | Drug therapy | HIV infection | Design | Antiretroviral drugs | Corporate sponsorship | Human immunodeficiency virus--HIV | Technological change | Research | Clinical medicine | Drugs | RNA-directed DNA polymerase | Exanthema | antiretroviral therapy | Lamivudine | Lipids | Nucleotides | Regression analysis | Efavirenz | CD4 antigen | nucleosides | Algorithms | Hospitals | non-nucleoside reverse transcriptase inhibitors | Abacavir | Zidovudine | Pharmaceuticals
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 238 - 246
Summary Background Efavirenz with tenofovir-disoproxil-fumarate and emtricitabine is a preferred antiretroviral regimen for treatment-naive patients infected... 
Internal Medicine | LAMIVUDINE | MEDICINE, GENERAL & INTERNAL | EFFICACY | SAFETY | COMBINATION THERAPY | GUIDELINES | PROTEASE-INHIBITOR | ANTIRETROVIRAL THERAPY | NEVIRAPINE | REGIMENS | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Adenine - adverse effects | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | Organophosphonates - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Adenine - administration & dosage | Benzoxazines - therapeutic use | Organophosphonates - administration & dosage | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Aged | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Dosage and administration | Efavirenz | Patient outcomes | Clinical trials | Antiretroviral drugs | Drug therapy | Human immunodeficiency virus--HIV
Journal Article
1998, Methods in molecular medicine, ISBN 9780896034778, Volume 11, xiv, 462
In Therapeutic Applications of Ribozymes, expert laboratory scientists describe in detail their methodologies for constructing ribozymes designed to elucidate... 
RNA, Catalytic | Laboratory manuals | Catalytic RNA | Gene Therapy | methods | Therapeutic use | Cytology | Cell Biology | Life Sciences
Book
Gastroenterology, ISSN 0016-5085, 2014, Volume 146, Issue 3, pp. 736 - 743.e1
Journal Article